68 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M Sell
Article Searches
LMNX or PACB: Which is a Better MedTech Investment Pick? http://www.zacks.com/stock/news/345680/lmnx-or-pacb-which-is-a-better-medtech-investment-pick?cid=CS-ZC-FT-345680 Jan 04, 2019 - Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.
An Easy Way To Arbitrage Profits: The GDL Fund https://seekingalpha.com/article/4229948-easy-way-arbitrage-profits-gdl-fund?source=feed_tag_editors_picks Dec 24, 2018 - Strategy for profiting in up, sideways, or down markets. Capture a double discount – deal spreads plus retail investor panic. This worked well in 2009 and could work well in 2019.
Here's Why You Should Hold Pacific Biosciences (PACB) Now http://www.zacks.com/stock/news/341454/heres-why-you-should-hold-pacific-biosciences-pacb-now?cid=CS-ZC-FT-341454 Dec 06, 2018 - Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat competition in the DNA sequencing market.
Here's Why You Should Invest in Illumina (ILMN) Stock Now http://www.zacks.com/stock/news/337968/heres-why-you-should-invest-in-illumina-ilmn-stock-now?cid=CS-ZC-FT-337968 Nov 16, 2018 - llumina (ILMN) set to take over peer in a $1.2-billion deal, which will strengthen its position in the genomics market.
Pacific Biosciences Bows Out Gracefully https://seekingalpha.com/article/4217720-pacific-biosciences-bows-gracefully?source=feed_sector_healthcare Nov 02, 2018 - PacBio's years of commercial execution struggles come to an end, with Illumina announcing its intention to buy the company for $8/share.Illumina should be able to meaningfully improve the margins of t
Week 38 Breakout Forecast: Short-Term Picks To Give You An Edge https://seekingalpha.com/article/4206573-week-38-breakout-forecast-short-term-picks-give-edge?source=feed_all_articles Sep 17, 2018 - Publishing two of the eight new Week 38 breakout stocks that are available only to subscribers, with better than 10% short-term upside potential.Performance results for the 1-week YTD (+54.16%) and to
Pacific Biosciences Inching Closer To A Key Event https://seekingalpha.com/article/4205968-pacific-biosciences-inching-closer-key-event?source=feed_sector_healthcare Sep 13, 2018 - PacBio continues to grind through a challenging period as customers delay instrument purchases and consumables revenue shifts away from legacy systems.The ZMW 8M launch remains a critical upcoming eve
Pacific Biosciences' Sequel Sees Solid Q2, Competition Rife http://www.zacks.com/stock/news/317392/pacific-biosciences-sequel-sees-solid-q2-competition-rife?cid=CS-ZC-FT-317392 Aug 10, 2018 - Pacific Biosciences (PACB) gains from solid presence in Asia; competition likely to mar results.
Here's Why Pacific Biosciences of California, Inc. Rose 40.3% in June https://www.fool.com/investing/2018/07/09/heres-why-pacific-biosciences-of-california-inc-ro.aspx?source=iedfolrf0000001 Jul 09, 2018 - The DNA sequencing leader announced upgrades to some of its core offerings.
Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report? http://www.zacks.com/stock/news/306116/why-is-pacific-biosciences-pacb-down-67-since-its-last-earnings-report?cid=CS-ZC-FT-306116 Jun 01, 2018 - Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pages: 1234567

Page 1>

Related Companies

Name Exchange Price Mkt Cap
QTRX Quanterix Corporation NASDAQ $16.52 $365.09M
FLDM Fluidigm Corporation NASDAQ $8.01 $313.7M
AXDX Accelerate Diagnostics, Inc. NASDAQ $21 $1.14B
HBIO Harvard Bioscience, Inc. NASDAQ $5.35 $195.7M
EYPT EyePoint Pharmaceuticals, Inc. NASDAQ $2.35 $175.1M
Sector: Capital Goods > Industry: Biotechnology: Laboratory Analytical Instruments
DeepLinks for Pacific Biosciences of California
PACB - Google Finance https://www.google.com/finance?q=PACB Industry related info and international coverage Summary News
PACB - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=PACB Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options